These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The 5-HT3 receptor as a therapeutic target. Thompson AJ; Lummis SC Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882 [TBL] [Abstract][Full Text] [Related]
24. Loop B is a major structural component of the 5-HT3 receptor. Thompson AJ; Lochner M; Lummis SC Biophys J; 2008 Dec; 95(12):5728-36. PubMed ID: 18931259 [TBL] [Abstract][Full Text] [Related]
25. Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA rho1 receptors lacking the large cytoplasmic M3M4 loop. Jansen M; Bali M; Akabas MH J Gen Physiol; 2008 Feb; 131(2):137-46. PubMed ID: 18227272 [TBL] [Abstract][Full Text] [Related]
26. Impact of intracellular domain flexibility upon properties of activated human 5-HT3 receptors. Kozuska JL; Paulsen IM; Belfield WJ; Martin IL; Cole DJ; Holt A; Dunn SM Br J Pharmacol; 2014 Apr; 171(7):1617-28. PubMed ID: 24283776 [TBL] [Abstract][Full Text] [Related]
28. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole. Hu XQ; Lovinger DM Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267 [TBL] [Abstract][Full Text] [Related]
29. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide. Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831 [TBL] [Abstract][Full Text] [Related]
30. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804 [TBL] [Abstract][Full Text] [Related]
31. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor. Lochner M; Lummis SC Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468 [TBL] [Abstract][Full Text] [Related]
32. Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor. Peters JA; Hales TG; Lambert JJ Trends Pharmacol Sci; 2005 Nov; 26(11):587-94. PubMed ID: 16194573 [TBL] [Abstract][Full Text] [Related]
33. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+. Hu XQ; Lovinger DM J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341 [TBL] [Abstract][Full Text] [Related]
34. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor. Yan D; White MM Mol Pharmacol; 2005 Aug; 68(2):365-71. PubMed ID: 15914697 [TBL] [Abstract][Full Text] [Related]
35. [The structural and dynamic model of the serotonin 5-HT3 receptor. Comparative analysis of the structure of the channel domain of pentameric ligand-gated ion channels]. Popinako AV; Levtsova OV; Antonov MIu; Nikolaev IN; Shaĭtan KV Biofizika; 2011; 56(6):1111-6. PubMed ID: 22279756 [TBL] [Abstract][Full Text] [Related]
36. Proline Residues in the Transmembrane/Extracellular Domain Interface Loops Have Different Behaviors in 5-HT Mosesso R; Dougherty DA; Lummis SCR ACS Chem Neurosci; 2019 Jul; 10(7):3327-3333. PubMed ID: 31273982 [TBL] [Abstract][Full Text] [Related]
37. Inter-residue coupling contributes to high-affinity subtype-selective binding of α-bungarotoxin to nicotinic receptors. Sine SM; Huang S; Li SX; daCosta CJ; Chen L Biochem J; 2013 Sep; 454(2):311-21. PubMed ID: 23802200 [TBL] [Abstract][Full Text] [Related]
38. Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop. Thompson AJ; Padgett CL; Lummis SC J Biol Chem; 2006 Jun; 281(24):16576-82. PubMed ID: 16595668 [TBL] [Abstract][Full Text] [Related]